For example, some TP53 mutants have been shown to interact with the ETS1 transcription factor leading to increased expression of multidrug-resistance 1 (MDR1) associated with a poor outcome in AML.142 Experimental evidence linked TP53 to GATA1 activity in normal erythropoiesis. Here, TP53 is linked to acute myeloid leukemia.